Results 161 to 170 of about 8,773 (221)

Epidemiological characteristics and natural history of porphyria - a twenty-year population-based analysis in Taiwan. [PDF]

Orphanet J Rare Dis
Wu WC, Yeh YH, Li CC, Wang YT, Chang YF, Chang CS, Wang RH, Wang JD, Kuo HC, Chen CH, Wu CH.   +10 more
europepmc   +1 more source

Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates. [PDF]

Gut
Córdoba KM, Jericó D, Jiang L, Collantes M, Alegre M, García-Ruiz L, Manzanilla O, Sampedro A, Herranz JM, Insausti I, Martinez de la Cuesta A, Urigo F, Alcaide P, Morán M, Martín MA, Lanciego JL, Lefebvre T, Gouya L, Quincoces G, Unzu C, Hervas-Stubbs S, Falcón-Pérez JM, Alegre E, Aldaz A, Fernández-Seara MA, Peñuelas I, Berraondo P, Martini PGV, Avila MA, Fontanellas A.   +29 more
europepmc   +1 more source

Hepatoerythropoietic Porphyria with Coexisting <i>BTD</i> And <i>CNGB1</i> Genetic Mutations: A First Case Report. [PDF]

Eur J Case Rep Intern Med
Kaya Ç, Heydari A, Kızılay O, Kızılay O, Sezgin G.   +4 more
europepmc   +1 more source

A novel acquired resistance mechanism to 5-aminolevulinic acid-mediated photodynamic therapy with ABCG2 inhibition. [PDF]

Photochem Photobiol
Chandratre S, Olsen J, Chen B.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chemical Synthesis of Porphobilinogen: Synthesis of Porphobilinogen and iso-Porphobilinogen Carboxylic Acids

Nature, 1955
Chemical Synthesis of Porphobilinogen: Synthesis of Porphobilinogen and iso-Porphobilinogen Carboxylic ...
K. S. N. PRASAD, R. RAPER
exaly   +2 more sources

Chemical Synthesis of Porphobilinogen: Decarboxylation of Porphobilinogen- and iso-Porphobilinogen-α-Carboxylic Acids

Nature, 1955
Chemical Synthesis of Porphobilinogen: Decarboxylation of Porphobilinogen- and iso-Porphobilinogen-α-Carboxylic ...
C. RIMINGTON, S. KROL
exaly   +2 more sources